Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Pravin Dugel

Ophthalmology Phoenix, AZ Medical Doctor

NPI 1780686766 CMS profile 353666

1101 E Missouri Ave, Phoenix, AZ 85014

Open in the dashboard

General payments

$175,814

158 records reported · program years 2019–2020

Research payments

$4,134

Paid to them · 2 records reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$303,326 paid to institutions, not to them · program years 2019–2023

Through program year 2020, Pravin Dugel of Phoenix, AZ is reported in the CMS Open Payments database as having received $175,814 across 158 general payments and $4,134 in research payments paid to them. Separately, studies naming them as principal investigator received $303,326 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $42,664 50
2020 Research $4,134 2
2019 General $133,150 108

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pravin Dugel
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Pravin Dugel were reported at $0. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Pravin Dugel Ophthalmology median Middle half National median
2019 $133,150 $258 $104–$655 $163
2020 $42,664 $126 $45–$321 $114
2021 $0 $205 $76–$534 $132
2022 $0 $266 $100–$678 $149
2023 $0 $308 $117–$745 $160
2024 $0 $340 $127–$846 $164
2025 $0 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Allergan Inc. $34,835 34 payments
  2. Alcon Research LLC $24,049 1 payment
  3. Novartis Pharmaceuticals Corporation $22,624 46 payments
  4. Novartis Pharma AG $18,628 6 payments
  5. Chugai Pharmaceutical Co., Ltd. $16,813 6 payments
  6. F. Hoffmann-La Roche AG $12,541 6 payments
  7. ThromboGenics, Inc. $10,000 2 payments
  8. Merck Sharp & Dohme Corporation $7,986 6 payments
  9. Genentech, Inc. $6,282 6 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $6,281 9 payments
  11. Other $15,774 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Consulting Fee $113,528 31 payments
  2. Royalty or License $24,049 1 payment
  3. Travel and Lodging $17,073 28 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,039 5 payments
  5. Food and Beverage $5,308 88 payments
  6. Honoraria $3,100 3 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,600 1 payment
  8. Education $118 1 payment
Products named General payments · program years 2019–2020
  1. Non-Covered Product $29,389 13 payments
  2. NGENUITY $24,049 1 payment
  3. RTH258A_BEOVU_OPHTHALMOLOGY $18,628 6 payments
  4. BEOVU $13,514 37 payments
  5. Jetrea $10,000 2 payments
  6. Lucentis $6,300 10 payments
  7. BUPARLISIB $5,497 2 payments
  8. OZURDEX $4,126 11 payments
  9. EYP-1901 $3,235 2 payments
  10. VITESSE $1,795 3 payments
  11. Other $4,094 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2020
  1. F. Hoffmann-La Roche AG $4,134 2 payments

Records

160 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record